Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Personalis, Inc.PSNL · Entity 4572 | President and CMO | September 18, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Personalis, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 169,882 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Sale · Disposed 3,998 · Balance 169,882 F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,618 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · derivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,728 Underlying: Common Stock · 9,618 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 4,436 | $21.22 | $94,131.92 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,413 F1 · shares: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $21.22, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 15,564 | $21.18 | $329,645.52 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $21.18, and the range of prices were between $20.87 and $21.83. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 15,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,331 shares of Common Stock acquired on October 30, 2020 and 538 shares of Common Stock acquired on April 30, 2021. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:06 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001179110-21-007744 · edgar.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2031-07-27 F2 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest monthly over four (4) from the Vesting Commencement Date, subject to the reporting person's Continuous Service. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 22:06 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007744 · edgar.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,980 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The shares shall vest in a series of eight (8) semi-annual installments measured from the Vesting Commencement Date, such that the award will be fully vested after four (4) years, subject to the reporting person's Continuous Service. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:09 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,101 | $22.75 | $25,047.75 |
DisclosureSEC source: 0001209191-21-042441 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,980 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 22:46 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 291 | $21.57 | $6,276.87 |
DisclosureSEC source: 0001209191-21-038399 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,081 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:20 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $19.74 | $0.00 |
DisclosureSEC source: 0001209191-21-033479 · doc4.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-05-15 F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments with the first installment vesting on June 15, 2021. Read SEC document |
| May 15, 2021 Filed May 18, 2021 20:20 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033479 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,372 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 8 equal semi-annual installments with the first installment vesting on November 15, 2021. F2 · balance_after: Includes 538 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on April 30, 2021. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,517 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-025313 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,945 Underlying: Common Stock · 12,517 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 12,517 | $25.69 | $321,561.73 |
DisclosureSEC source: 0001209191-21-025313 · doc4.xml · nonDerivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,834 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 12,517 | $0.44 | $5,507.48 |
DisclosureSEC source: 0001209191-21-025313 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 6,260 | $25.96 | $162,509.60 |
DisclosureSEC source: 0001209191-21-025313 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,834 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $25.96, and the range of prices were between $25.86 and $26.20. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 21,223 | $25.61 | $543,521.03 |
DisclosureSEC source: 0001209191-21-025313 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,094 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $25.61, and the range of prices were between $24.84 and $25.82. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 21:48 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,130 | $26.73 | $30,204.90 |
DisclosureSEC source: 0001209191-21-022150 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,317 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 02, 2021 Filed Mar 5, 2021 00:21 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 345 | $32.60 | $11,247.00 |
DisclosureSEC source: 0001209191-21-018009 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,447 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,422 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · derivative · entry 6 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,462 Underlying: Common Stock · 13,422 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 11,022 | $38.80 | $427,653.60 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · nonDerivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,792 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F5 · price: The weighted average sale price for the transaction reported was $38.80, and the range of prices were between 38.58 and 39.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 2,400 | $38.12 | $91,488.00 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · nonDerivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $38.12, and the range of prices were between 37.56 and 38.54. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 13,422 | $0.44 | $5,905.68 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 20,059 | $38.83 | $778,890.97 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,792 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $38.83, and the range of prices were between 38.57 and 39.28. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 23:24 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 6,519 | $38.19 | $248,960.61 |
DisclosureSEC source: 0001209191-21-007439 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,851 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $38.19, and the range of prices were between 37.56 and 38.54. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 23:18 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,087 | $36.37 | $39,534.19 |
DisclosureSEC source: 0001209191-20-064704 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,370 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 293 | $27.76 | $8,133.68 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · nonDerivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,457 F4 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $28.17 | $0.00 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · derivative · entry 6 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-12-01 F6 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments starting on April 16, 2023. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,884 Underlying: Common Stock · 40,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 25,612 | $28.14 | $720,721.68 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $28.14, and the range of prices were between $28.025 and $28.43. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 14,388 | $27.75 | $399,267.00 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,362 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $27.75, and the range of prices were between $27.02 and $28.01. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:23 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 40,000 | $0.44 | $17,600.00 |
DisclosureSEC source: 0001209191-20-061669 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,452 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · derivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,884 Underlying: Common Stock · 37,452 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 26,528 | $22.26 | $590,513.28 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $22.26, and the range of prices was between $22.10 and $22.54. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 13,472 | $21.67 | $291,938.24 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,278 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $21.67, and the range of prices was between $21.03 and $22.02. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 37,452 | $0.44 | $16,478.88 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 23:05 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,120 | $22.74 | $25,468.80 |
DisclosureSEC source: 0001209191-20-051372 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,298 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:39 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 291 | $22.99 | $6,690.09 |
DisclosureSEC source: 0001209191-20-049655 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,418 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 653 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · derivative · entry 6 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,346 Underlying: Common Stock · 653 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 27,913 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,336 Underlying: Common Stock · 27,913 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,200 | $20.47 | $24,564.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,709 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $20.47, and the range of prices was between $20.45 to $20.48 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 27,366 | $20.17 | $551,972.22 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $20.17, and the range of prices was between $19.45 to $20.44 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 3,434 | $19.76 | $67,855.84 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,275 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F2 · price: The weighted average sales price for the transaction reported was $19.76, and the range of prices was between $19.36 and $20.18 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 28,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:48 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,085 | $12.37 | $13,421.45 |
DisclosureSEC source: 0001209191-20-038758 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,143 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 05, 2020 Filed Jun 11, 2020 23:06 UTC Amendment | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 272 | $14.34 | $3,900.48 |
DisclosureSEC source: 0001209191-20-036075 · doc4a.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,228 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 23:21 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 289 | $13.19 | $3,811.91 |
DisclosureSEC source: 0001209191-20-034273 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,211 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 27, 2020 Filed Mar 27, 2020 23:59 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · derivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,249 Underlying: Common Stock · 15,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 27, 2020 Filed Mar 27, 2020 23:59 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 23:59 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,249 Underlying: Common Stock · 10,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 23:59 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:44 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-020140 · doc4.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-03-16 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 16, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.